NRCT-202XR

N/A

Report date: 2026/01/16 20:01:23
NME

Base Information

Drug NameNRCT-202XR
Drug Alias NameNRCT-202XR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeurocentria Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurocentria Inc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A